Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase

Blood

Volumn 98, Issue 4, 2001, Pages 1003-1011

  Hadjur, Suzana ^a,b,c   Ung, Karen ^a,b,c   Wadsworth, Louis ^a,b,c   Dimmick, James ^a,b,c   Rajcan Separovic, Evica ^a,b,c   Scott, Richard W ^a,b,c   Buchwald, Manuel ^a,b,c   Jirik, Frank R ^a,b,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CEPHALON INC   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FANCONI ANEMIA COMPLEMENTARY GROUP C PROTEIN; GENE PRODUCT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROID CELL; FANCONI ANEMIA; FATTY LIVER; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC CELL; LEUKOCYTE; LIVER CELL MEMBRANE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

EID: 0035883043     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.4.1003     Document Type: Article

References (59)

1. Fanconi G. Familial constitutional panmyelocytopathy, Fanconi anemia (F.A.). Semin Hematol. 1967;4:233-240.
2. Scriver CR. The Metabolic and Molecular Bases of Inherited Disease, 7th ed. New York: McGraw-Hill; 1995.
3. Ishida R, Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. Cancer Res. 1982;42:4000-4006.
4. Lo Ten Foe JR, Rooimans MA, Bosnoyan Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet. 1996;14:320-323.
5. Consortium FABC. Positional cloning of the Fanconi anemia group A gene. Nat Genet. 1996;14:324-328.
6. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anemia by functional complementation. Nature. 1992;356:763-767.
7. de Winter JP, Waisfisz Q, Rooimans MA, et al. The Fanconi anemia group G gene FANCG is identical with XRCC9. Nat Genet. 1998;20:281-283.
8. de Winter JP, Rooimans MA, van Der Weel L, et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet. 2000;24:15-16.
9. de Winter JP, Leveille F, van Berkel CG, et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet. 2000;67:1306-1308.
10. Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7:241-248.
11. Buchwald M. Complementation groups: one or more per gene? Nat Genet. 1995;11:228-230.
12. Wevrick R, Clarke CA, Buchwald M. Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genet. 1993;2:655-662.
13. Whitney MA, Royle G, Low MJ, et al. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with targeted disruption of the Fanconi anemia C gene. Blood. 1996;88:49-58.
14. Chen M, Tomkins DJ, Auerbach W, et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet. 1996;12:448-451.
15. Buchwald M, Moustacchi E. Is Fanconi anemia caused by a defect in the processing of DNA damage? Mutat Res. 1998;408:75-90.
16. Pagano G. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype. Carcinogenesis. 2000;21:1067-1068.
17. Ruppitsch W, MeiBlitzer C, Hirsch Kauffmann M, Schweiger M. Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane. FEBS Lett. 1998;422:99-102.
18. Schindler D, Hoehn H. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet. 1988;43:429-435.
19. Joenje H, Arwert F, Eriksson AW, de Koning H, Oostra AB. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature. 1981;290:142-143.
20. Kubbies M, Schindler D, Hoehn H, Schinzel A, Rabinovitch PS. Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells. Am J Hum Genet. 1985;37:1022-1030.
21. Korkina LG, Samochatova EV, Maschan AA, et al. Release of active oxygen radicals by leukocytes of Fanconi anemia patients. J Leukoc Biol. 1992;52:357-362.
22. Degan P, Bonassi S, de caterina M, et al. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anemia families. Carcinogenesis. 1995;16:735-742.
23. Ruppitsch W, Meiblitzer C, Weirich Schwaiger H, et al. The role of oxygen metabolism for the pathological phenotype of Fanconi anemia. Hum Genet. 1997;99:710-719.
24. Kruyt FAE, Hoshino T, Liu JM, et al. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood. 1998;92:3050-3056.
25. Shefner JM, Reaume AG, Flood DG, et al. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology. 1999;53:1239-1246.
26. Flood DG, Reaume AG, Gruner JA, et al. Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am J Pathol. 1999;155:663-672.
27. Ho Y, Gargano M, Cao J, et al. Reduced fertility in female mice lacking copper-ainc superoxide dismutase. J Biol Chem. 1998;273:7765-7769.
28. Reaume AG, Elliott JL, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet. 1996;13:43-47.
29. Kondo T, Reaume AG, Huang TT, et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci. 1997;17:4180-4189.
30. Huang TT, Yasunami M, Carlson EJ, et al. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch Biochem Biophys. 1997;344:424-432.
31. Applegate LA, Luscher P, Tyrrell RM. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 1991;51:974-978.
32. Otterbein LE, Kolls JK, Mantell LL, et al. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest. 1999;103:1047-1054.
33. Yeh CC, Wan XS, St Clair DK. Transcriptional regulation of the 5′ proximal promoter of the human manganese superoxide dismutase gene. DNA Cell Biol. 1998;17:921-930.
34. Williams MD, Van Remmen H, Conrad CC, et al. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem. 1998;273:28510-28515.
35. Doull CA. Toxicology: The Basic Science of Poisons. 5th ed. New York: McGraw-Hill; 1996.
36. Hancock JT. Superoxide, hydrogen peroxide and nitric oxide as signalling molecules; their production and role in disease. Br J Biomed Sci. 1997;54:38-46.
37. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury. Drug Metab Reviews. 1995;209:104-111.
38. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int. 1999;49:91-102.
39. Lebovitz RM, Zhang H, Vogel H, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U A A. 1996;93:9782-9787.
40. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998;10:248-253.
41. Dalton TP, Shertzer HG, Puga A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol. 1999;39:67-101.
42. Nordenson I. Effect of superoxide dismutase and catalase on spontaneously occurring chromosomal breaks in patients with Fanconi's anemia. Hereditas. 1977;86:147-150.
43. Nagasawa H, Little JB. Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts. Carcinogenesis. 1983;4:795-798.
44. Joenje H, Eriksson AW, Frants RR, Arwert F, Houwen B. Erythrocyte superoxide-dismutase deficiency in Fanconi's anaemia. Lancet. 1978;1:204.
45. Okahata S, Kobayashi Y, Usui T. Erythrocyte superoxide dismutase activity in Fanconi's anaemia. Clin Sci (Colch). 1980;58:173-175.
46. Mavelli I, Ciriolo MR, Rotilio G, et al. Superoxide dismutase, glutathione peroxidase and catalase in oxidative hemolysis. A study of Fanconi's anemia erythrocytes. Biochem Biophys Res Commun. 1982;106:286-290.
47. Hautekeete ML, Degott C, Benhamou JP: Microvesicular steatosis of the liver. Acta Clin Belg. 1990;45:311-326.
48. Alter BP, Knobloch ME, Weinberg RS. Erythropoiesis in Fanconi's anemia. Blood. 1991;78:602-608.
49. Bagnara GP, Strippoli P, Bonsi L, et al. Effect of stem cell factor on colony growth from acquired and constitutional (Fanconi) aplastic anemia. Blood. 1992;80:382-387.
50. Stark R, Thierry D, Richard P, Gluckman E. Long-term bone marrow culture in Fanconi's anemia. Br J Haematol. 1993;83:554-559.
51. Haneline LS, Broxmeyer HE, Cooper S, et al. Multiple inhibitory cytokines induce deregulated progeitor growth and apoptosis in hematopoietic cells from Fac-/-mice. Blood. 1998;91:4092-4098.
52. Haneline LS, Gobbett TA, Ramani R, et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood. 1999;94:1-8.
53. D'Andrea AD, Grompe M: Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood. 1997;90:1725-1736.
54. Nathan DG, Orkin SH. Hematology of Infancy and Childhood, vol 2. 5th ed. Philadelphia: Saunders; 1998.
55. Rhee SG, Bae YS, Lee S, Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cystein oxidation. Science. 2000;53:1-6.
56. Sattler M, Winkler T, Verma S, et al. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood. 1999;93:2928-2935.
57. McCord JM, Fridovich I. The biology and pathology of oxygen radicals. Annals of Int Medicine. 1978;89:122-127.
58. Tyler WS, Stohlman F Jr, Chovaniec M, Howard D. Effect of a congenital defect in hemopoiesis on myeloid growth and the stem cell (CFU) in an in vivo culture system. Blood. 1976;47:413-421.
59. Pang Q, Fagerlie S, Christianson TA, et al. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Mol Cell Biol. 2000;20:4724-4735.